Nanocrine - Press Conference Announcement

Preview of breakthrough research to be unveiled Dec. 6^th

WHEN:

Dec 4, 2025 at 9:30am

WHERE:

Bloomberg Room
https://www.press.org/events/press-conference

WASHINGTON, Nov. 3, 2025 /PRNewswire/ -- Preview of breakthrough research to be formally unveiled at the Dec. 6th CELL BIO2025 Meting of American Society of Cell Biologists, Philadelphia. Nanocrine's revolutionary RT Chip™ for plasmonic live cell imaging for the first time enables scientists the ability to visualize cell-to-cell signaling as it is occurring in time and space, for single cells or tissue architectures.

"FITCI and its incubator beneficiary Nanocrine are proud to be the first to publicly demonstrate a new cellular imaging platform that has the potential to transform the lives of people living with cancer, diabetes and so many other debilitating diseases," says Kathie Callahan Brady, company advisor, and CEO of the Frederick Innovative Tech Center Inc (FITCI) where Nanocrine's HQ is located. "This is a double success story because it proves how a small, start-up business can make a difference to its community while igniting industry-changing innovation that drives breakthroughs and gives people back their health."

Nanocrine's advancement in unlocking extracellular communications fills a gap in our understanding of human disease, propelling the development of new therapies for the treatment of wound healing, cancer metastasis; viral pathogenesis; aging & senescence; for cardiomyopathies; regenerative and neurodegenerative and other disorders. Nanocrine's cutting edge technology was developed through a strong partnership with the US. Naval Research Laboratory, supported by FITCI; State of Maryland's TEDCO; as well as collaborations with the National Institutes of Health (National Cancer Institute & National Center for Advancing Translational Sciences); Virginia Tech; and the Johns Hopkins School of Medicine.

Speaker Invitees:

Maryland Gov. Wes Moore
Cancer survivor & former MD Gov Larry Hogan

Company Advisors:

Hon. Tommy G. Thompson, Former WI Governor & HHS Secretary

Elias A. Zerhouni, MD, Former Director, National Institutes of Health

Mat Winter RADM, USN (Ret), Former Chief of Naval Research

Science Team from Naval Research Laboratory

Kathie Callahan Brady, CEO of the Frederick Innovative Technology Center, Inc. Representatives from Virginia Tech & Johns Hopkins University

Ted Gresser, State of Maryland's TEDCO

Organizational Invitees include:

American Society of Cell Biologists
American Cancer Society
American Diabetes Association
International Association of Physicians in AIDS Care
National Cancer Institute
National Center for Advancing Translational Science

View original content to download multimedia:https://www.prnewswire.com/news-releases/nanocrine---press-conference-announcement-302600042.html

SOURCE Nanocrine